帕金森酶疗法迈向临床，里程碑付款最高达11.7亿美元

The Parkinson’s enzyme therapy is still heading toward the clinic, and the deal could grow by up to $1.17bn in milestone payments.

来源：Longevity.Technology (@LongevityTech) · x.com